Results 161 to 170 of about 26,660 (304)

Novel approaches for drug development against chronic primary pain: A systematic review

British Journal of Pharmacology, EarlyView.
Abstract Chronic primary pain (CPP) persisting for more than 3 months, associated with significant emotional distress without any known underlying cause, is an unmet medical need. Traditional or adjuvant analgesics do not provide satisfactory pain relief for a great proportion of these patients.
Valéria Tékus, Éva Borbély, Andreas Goebel, Ralf Baron, Zsófia Hajna, Zsuzsanna Helyes   +5 more
wiley   +1 more source

Maximal scapular protraction increases the safety distance of the spinal accessory nerve during lower trapezius tendon harvest: a cadaveric study. [PDF]

JSES Int
Hachem AI, Fargues B, Barraza G, Alvarado F, Rius X, Agullo JL, Gonzalez-Morgado D, Elhassan B.   +7 more
europepmc   +1 more source

Clinical remarks on the proclivity of the abductor fibres of the recurrent laryngeal nerve to become affected sooner than the adductor fibres, or even exclusively, in cases of undoubted central or peripheral injury or disease of the roots or trunks of the pneumogastric, spinal accessory, or recurrent nerves [PDF]

, 2009
Semon, Felix
core  

Vestibulo-Spinal Pathways in Tetrapods [PDF]

The vestibulospinal system provides the spinal motor circuits controlling head/neck and limb movements and body posture with rapid reflex adjustments to maintain equilibrium and stability and with a continuous essential excitatory drive, called tonus, to
Boyle, Richard
core   +1 more source

Cannabigerol reverses mechanical allodynia through α2A‐adrenergic modulation of thalamocortical signaling in chemotherapy‐induced neuropathy

British Journal of Pharmacology, EarlyView.
Abstract Background and Purpose Chemotherapy‐induced peripheral neuropathy (CIPN) is a prevalent and treatment‐resistant side effect of platinum‐based chemotherapy, characterised by mechanical allodynia. Cannabigerol (CBG), a non‐psychoactive cannabinoid, has shown antinociceptive potential, but its site and mechanism of action remain unclear.
Quinn W. Wade, Nathan Morris, Diana E. Sepulveda, Alonso Cortez‐Resendiz, Christopher Brandl, Jennifer E. Lausch, Mariya Starostina, Nicholas M. Graziane   +7 more
wiley   +1 more source

Superior spinal accessory nerve function after robotic versus open selective neck dissection in papillary thyroid carcinoma: a retrospective and prospective cohort study. [PDF]

J Robot Surg
Fang Y, Yue K, Li H, Wang Y, Liu J, Li X, Shi W, Chen S, Yang A, Ding Y, Zhang J, Shi R, Wu Y, Duan Y, Wang X.   +14 more
europepmc   +1 more source

Isolated musculocutaneous nerve involvement in COVID-19 related Neuralgic amyotrophy. Comment on: "Neuralgic amyotrophy and COVID-19 infection: 2 cases of spinal accessory nerve palsy" by Coll et al. Joint Bone Spine 2021;88:105196. [PDF]

Joint Bone Spine, 2021
Cabona C, Zaottini F, Pistoia F, Grisanti S, Schenone C, Villani F, Schenone A, Aloé T, Reni L, Benedetti L.   +9 more
europepmc   +1 more source

Functional morphology of the lower lumbar spine [PDF]

, 1989
Putz, Reinhard
core  

Novel drugs approved by the EMA, the FDA and the MHRA in 2025: A year in review

British Journal of Pharmacology, EarlyView.
Abstract In the 2025 novel drug mini‐review, one can take a full measure of the ingenuity that underlies current drug design and development, despite the year's smaller harvest (46 novel drugs) compared to 2024 (53) and 2023 (70). 54% of the novel drugs are first‐in‐class (FIC).
Andreas Papapetropoulos, Stavros Topouzis, Steve P. H. Alexander, Miriam M. Cortese‐Krott, Zsuzsanna Helyes, Kirill Martemyanov, Claudio Mauro, Nithyanandan Nagercoil, Reynold A. Panettieri Jr, Hemal H. Patel, Rainer Schulz, Barbara Stefanska, Gary J. Stephens, Nathalie Vergnolle, Xin Wang, Stephen Ward, Péter Ferdinandy   +16 more
wiley   +1 more source

High-resolution ultrasound imaging of the spinal accessory nerve and associated injuries based on a prospective normative study and retrospective analysis. [PDF]

Sci Rep
Tai Z, Liu L, Wang T, Wang Y, Qin K, Chen W, Zhang H, Qi H.   +7 more
europepmc   +1 more source